相关实验视频

Updated: May 5, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

基于多功能离子凝的5-甲通过皮肤输送,用于乳腺癌治疗

Raviraj Pansuriya¹, Tapas Patel¹, Sugam Kumar²

¹Ionic Liquids Research Laboratory, Department of Chemistry, Sardar Vallabhbhai National Institute of Technology, Surat395007, Gujarat ,India.

ACS applied bio materials

|April 15, 2024

概括

离子凝增强了乳腺癌治疗的通过皮肤递送药物. 这些生物相容系统改善了5-甲的透性,并显示出高细胞活力,提供了一个有前途的局部治疗方法.

科学领域:

生物材料科学生物材料科学
药物输送系统药物输送系统
癌症治疗方法癌症治疗方法

背景情况:

通过皮肤递送药物系统 (TDDS) 提供非侵入性乳腺癌治疗,局部递送和减少全身副作用.
水凝是具有高药载荷能力的多功能生物材料,适用于先进的药物输送应用.
离子液 (ILs) 和油酸 (OA) 可用于创建新型水凝配方,以提高药物的溶解性和穿透皮肤.

研究的目的:

开发和描述新的离子水凝,用于通过皮肤输送5-甲 (5-FU),用于乳腺癌治疗.
研究特定离子液体 ([Cho][Ala],[Cho][Pro]) 和油酸对水凝形成和药物透的协同作用.
评估开发的水凝的生物相容性,机械性能和体外疗效.

主要方法:

使用胆氨酸 ([Cho][Ala]) 或胆プロ林 ([Cho][Pro]) 与油酸 (OA) 合成的离子水凝.
使用小角度中子散射 (SANS) 和富里埃转换红外光谱 (FTIR) 进行了水凝形态和相互作用的特征.
机械性能通过风湿学来评估,皮肤透率在体外被研究. 细胞毒性在正常和癌细胞系上进行了评估.

主要成果:

氧化的度影响了离子水凝的形态,形成从小粒到水凝的结构.
与PBS相比,体外皮肤透研究显示,5-FU (255x和250x) 的透率显著增加.
水凝在48小时后显示出优异的生物相容性,在L-132和MCF-7细胞系中超过92%的细胞活力.

结论:

开发的离子水凝是生物相容的,有效地增强了像5-FU这样的水友性药物的通过皮肤传递.
这些水凝显示出作为乳腺癌可行的局部治疗策略的潜力,最大限度地减少全身暴露.
这项研究强调了基于IL的水凝对先进的透皮治疗应用的前景.

关键词:

5 - - 甲酸是一种5 - - 甲.乳腺癌乳腺癌乳腺癌这是一种水凝.离子液体是一种离子液体.油酸油脂酸的使用方法皮肤透增强剂增强器通过皮肤递送药物系统.

更多相关视频

Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models

Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models

Published on: April 1, 2022

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

相关概念视频

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Transdermal Drug Delivery Systems

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...